Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 3, 2013, Pages 411-422

  Zhang, Xiao Yun ^a   Qiao, Hua ^a   Ni, Jing Man ^a   Shi, Yan Bin ^a   Qiang, Yin ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Antitumor; Biodistribution; Hepatoma 22; Isoliquiritigenin; Nanostructured lipid carrier; Sarcoma 180

Indexed keywords

ISOLIQUIRITIGENIN; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RELEASE; IMMUNOMODULATION; IN VIVO STUDY; INHIBITION KINETICS; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHALCONES; DRUG CARRIERS; FEMALE; GLYCEROL; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NANOSTRUCTURES; SARCOMA; TISSUE DISTRIBUTION; TRIGLYCERIDES; TUMOR BURDEN;

EID: 84877812976     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.04.020     Document Type: Article

References (54)

1. M. Baba, R. Asano, I. Takigami, T. Takahashi, M. Ohmura, Y. Okada, H. Sugimoto, T. Arika, H. Nishino, and T. Okuyama Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis Biol. Pharm. Bull. 25 2002 247 250
2. N. Chiannilkulchai, N. Ammoury, B. Caillou, J. Devissaguet, and P. Couvreur Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice Cancer Chemother. Pharmacol. 26 1990 122 126
3. + current in H9c2 Cells J. Mol. Cell. Cardiol. 44 2008 444 453
4. M. Cirri, M. Bragagni, N. Mennini, and P. Mura Development of a new delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for ketoprofen topical delivery Eur. J. Pharm. Biopharm. 80 2012 46 53
5. C. Fang, B. Shi, Y.Y. Pei, M.H. Hong, J. Wu, and H.Z. Chen In vivo tumor targeting of tumor necrosis factor-a-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size Eur. J. Pharm. Sci. 27 2006 27 36
6. D.B. Fenske, and P.R. Cullis Liposomal nanomedicines Expert Opin. Drug Deliv. 5 2008 25 44
7. H. Hayashi, N. Hiraoka, Y. Ikeshiro, and H. Yamamoto Organ specific localization of flavonoids in Glycyrrhiza glabra L Plant Sci. 116 1996 233 238
8. H. Hayashi, N. Hiraoka, Y. Ikeshiro, H. Yamamoto, and T. Yoshikawa Seasonal variation of glycyrrhizin and isoliquiritigenin glycosides in the root of Glycyrrhiza glabra L Biol. Pharm. Bull. 21 1998 987 989
9. T. He, C. Tang, S. Xu, T. Moyana, and J. Xiang Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity Cell. Mol. Immunol. 4 2007 105 111
10. Y.L. Hsu, P.L. Kuo, and C.C. Lin Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells Life Sci. 77 2005 279 292
11. T. Ii, Y. Satomi, D. Katoh, J. Shimada, M. Baba, T. Okuyama, H. Nishino, and N. Kitamura Induction of cell cycle arrest and p21 (CIP1/WAF1)expression in human lung cancer cells by isoliquiritigenin Cancer Lett. 207 2004 27 35
12. N. Ikuhiko, L. Henry, P. Narendra, and T.S. Singh Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation Int. J. Pharm. 354 2008 28 33
13. N. Iodoshima, C. Udagawa, T. Ando, H. Fukuyasu, H. Watanabe, and S. Nakabayashi Lipid nanoparticles for delivering antitumor drugs Int. J. Pharm. 146 1997 81 92
14. K. Iwashita, M. Kobori, K. Yamaki, and T. Tsushida Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells Biosci. Biotechnol. Biochem. 64 2000 1813 1820
15. V. Jenning, and S.H. Gohla Encapsulation of retinoids in solid lipid nanoparticles J. Microencapsul. 18 2001 149 158
16. V. Jenning, A.F. Thünemann, and S.H. Gohla Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids Int. J. Pharm. 199 2000 167 177
17. J.I. Jung, S.S. Lima, H.J. Choi, H.J. Cho, H.K. Shin, E.J. Kim, W.Y. Chung, and P.J.H. Yoon Park Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells J. Nutr. Biochem. 17 2006 689 696
18. M. Kanazawa, Y. Satomi, Y. Mizutani, O. Ukimura, A. Kawauchi, T. Sakai, M. Baba, T. Okuyama, H. Nishino, and T. Miki Isoliquiritigenin inhibits the growth of prostate cancer Eur. Urol. 43 2003 580 586
19. D.C. Kim, S. Ramachandran, S.H. Baek, S.H. Kwon, K.Y. Kwon, S.D. Cha, I. Bae, and C.H. Cho Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin Reprod. Sci. 15 2008 552 558
20. S.C. Kim, S.H. Byun, C.H. Yang, C.Y. Kim, J.W. Kim, and S.G. Kim Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage) Toxicology 197 2004 239 251
21. I. Kitagawa, W.Z. Chen, K. Hori, E. Harada, N. Yasuda, M. Yoshikawa, and J. Ren Chemical studies of Chinese licorice-roots I. Elucidation of five new flavonoid constituents from the roots of Glycyrrhiza glabra L. collected in Xinjiang Chem. Pharm. Bull. 42 1994 1056 1062
22. I. Kitagawa, W.Z. Chen, K. Hori, M. Kobayashi, and J. Ren As a continuation of investigations the title roots are examined and five novel compounds such as (I)-(IV) are isolated Chem. Pharm. Bull. 46 1998 1511 1517
23. S. Kobayashi, T. Miyamoto, I. Kimura, and M. Kimura Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro Biol. Pharm. Bull. 18 1995 1382 1386
24. N. Koshkina, J. Waldrep, and V. Knight Camptothecins and lung cancer: improved delivery systems by aerosol Curr. Cancer Drug Targets 3 2003 251 264
25. R. Langer Biomaterials in drug delivery and tissue engineering: one laboratory's experience Acc. Chem. Res. 33 2000 94 101
26. D.H. Liu, Z.H. Liu, L.L. Wang, C. Zhang, and N. Zhang Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel Colloid Surf. B: Biointerfaces 85 2011 262 269
27. P.E. Lonning Study of suboptimum treatment response: lessons from breast cancer Lancet Oncol. 4 2003 177 185
28. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
29. M. Maggiolini, G. Statti, A. Vivacqua, S. Gabriele, V. Rago, M. Loizzo, F. Menichini, and S. Amdo Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells J. Steroid Biochem. Mol. Biol. 82 2002 315 322
30. J. Ma, N.Y. Fu, D.B. Pang, W.Y. Wu, and A.L. Xu Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells Planta Med. 67 2001 754 757
31. W. Mehnert, and K. Mader Solid lipid nanoparticles production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
32. K. Mitri, R. Shegokar, S. Gohla, C. Anselmi, and R.H. Müller Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance Int. J. Pharm. 414 2011 267 275
33. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
34. M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin, B. Pitard, J.P. Benoit, and C. Passirani Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting Biomaterials 31 2010 321 329
35. R.H. Müller, and C.M. Keck Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles J. Biotechnol. 113 2004 151 170
36. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 2002 131 155
37. I. Park, K.K. Park, J.H.Y. Park, and W.Y. Chung Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase/anaphase transition Cancer Lett. 277 2009 174 181
38. M. Rawat, D. Singh, S. Saraf, and S. Saraf Lipid carrier: a versatile delivery vehicle for proteins and peptides Yakugaku Zasshi 128 2008 269 280
39. M. Schäfer-Korting, W. Mehnert, and H.C. Korting Lipid nanoparticles for improved topical application of drugs for skin diseases Adv. Drug Deliver. Rev. 59 2007 427 443
40. K.M. Semnani, M. Saeedi, and M. Hamidian Anti-inflammatory and analgesic activity of the topical preparation of Glaucium grandiflorum Fitoterapia 75 2004 123 129
41. A. Smets Programmed cell death (apoptosis) and response to anti-cancer drugs Anticancer Drug 5 1994 3 9
42. C.E. Soma, C. Dubernet, G. Barratt, S. Benita, and P. Couvreur Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro J. Control. Release 68 2000 283 289
43. E.B. Souto, S.A. Wissing, C.M. Barbosa, and R.H. Müller Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Int. J. Pharm. 278 2004 71 77
44. T. Takahashi, N. Takasuka, M. Iigo, M. Baba, H. Nishino, and H. Tsuda Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development Cancer Sci. 95 2004 448 453
45. W.P. Tarl, E.G. Jeffrey, L.L. Lynlee, F. Rokhaya, B. Margaret, B. Wolfgang, M.T. Elisabeth, Y. Corinne, A.R. Thomas, H.P. Soyer, and S.R. Michael Nanoparticles and microparticles for skin drug delivery Adv. Drug Deliv. Rev. 63 2011 470 491
46. J. Vaya, P.A. Belinky, and M. Aviram Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation Free Radical Biol. Med. 23 1997 302 313
47. L.E.V. Vlerken, Z. Duan, S.R. Little, M.V. Seiden, and M.M. Amiji Biodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model Mol. Pharm. 5 2008 516 526
48. Y.Q. Wei, M.J. Huang, L. Yang, X. Zhao, L. Tian, Y. Lu, J.M. Shu, C.J. Lu, T. Niu, B. Kang, Y.Q. Mao, F. Liu, Y.J. Wen, S. Lei, F. Luo, L.Q. Zhou, F. Peng, Y. Jiang, J.Y. Liu, H. Zhou, Q.R. Wang, Q.M. He, F. Xiao, Y.Y. Lou, X.J. Xie, Q. Li, Y. Wu, Z.Y. Ding, B. Hu, M. Hu, and W. Zhang Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen Proc. Natl. Acad. Sci. USA 98 2001 11545 11550
49. S. Yamazaki, T. Morita, H. Endo, T. Hamamoto, M. Baba, Y. Joichi, S. Kaneko, Y. Okada, T. Okuyama, H. Nishino, and A. Tokue Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma Cancer Lett. 183 2002 23 30
50. X.L. Yu, W. Wang, and M. Yang Antioxidant activities of compounds isolated from Dalbergia odorifera T. Chen and their inhibition effects on the decrease of glutathione level of rat lens induced by UV irradiation Food Chem. 104 2007 715 720
51. L.Y. Zhang, M. Yang, Q. Wang, Y. Li, R. Guo, X.Q. Jiang, C.Z. Yang, and B.R. Liu 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice J. Control. Release 119 2007 153 162
52. X.Y. Zhang, J.P. Liu, H. Qiao, H. Liu, J.M. Ni, W.L. Zhang, and Y.B. Shi Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology Powder Technol. 197 2010 120 128
53. X.Y. Zhang, J.P. Liu, H. Qiao, J.M. Ni, and Y.B. Shi Determination and pharmacokinetics of Isoliquiritigenin in rat plasma by reverse phase high-performance liquid chromatography after intravenous administration Chromatographia 70 2009 423 430
54. Z.S. Zhu, Y. Li, X.L. Li, R.T. Li, Z.J. Jia, B.R. Liu, W.H. Guo, W. Wu, and X.Q. Jiang Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(e-caprolactone) nanoparticles: preparation and antitumor activity in vivo J. Control. Release 142 2010 438 446